By contrast, in hepatocellular carcinoma, CAFs secrete IL-6 to mediate STAT3 activation, convert normal DCs into cells with high IDO1 expression and educate them to acquire a tolerogenic phenotype [62]. This evidence concerns the gene IDO1 and hepatocellular carcinoma.